SKI Market

A+| A| A-|

Indian Indices

Sensex

76,536.83 47.87
( 0.06%)

Global Indices

Nasdaq

50,600.70 294.03
(0.58%)

Dow Jones

7,494.47 27.75
(0.37%)

Hang Seng

65,182.04 1,842.97
(2.91%)

Nikkei 225

10,466.26 22.79
(0.22%)

Forex

USD-INR

95.61 -0.67
(-0.70%)

EUR-INR

110.97 -0.85
(-0.76%)

GBP-INR

128.43 -0.86
(-0.66%)

JPY-INR

0.60 0.00
(-0.79%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Bliss GVS Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

506197

INE416D01022

109.1974783

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BLISSGVS

34.15

3359.86

EPS(TTM)

Face Value()

Div & Yield %

9.3

0.47

Back

Simplex Realty reports consolidated net loss of Rs 0.36 crore in the December 2025 quarter

Feb 11,2026

Net loss of Simplex Realty reported to Rs 0.36 crore in the quarter ended December 2025 as against net profit of Rs 0.47 crore during the previous quarter ended December 2024. Sales declined 19.23% to Rs 0.21 crore in the quarter ended December 2025 as against Rs 0.26 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	0.21	0.26	-19
OPM %	-504.76	-576.92	-
PBDT	-0.46	0.74	PL
PBT	-0.50	0.70	PL
NP	-0.36	0.47	PL

76,536.83 47.87 ( 0.06%)

50,600.70 294.03 (0.58%)

7,494.47 27.75 (0.37%)

65,182.04 1,842.97 (2.91%)

10,466.26 22.79 (0.22%)

95.61 -0.67 (-0.70%)

110.97 -0.85 (-0.76%)

128.43 -0.86 (-0.66%)

0.60 0.00 (-0.79%)